The new report by Expert Market Research titled, ‘Global Immunoglobulin Market Analysis, Share, Price, Trends, Growth, Report and Forecast 2023-2028’, gives an in-depth analysis of the global immunoglobulin market, assessing the immunoglobulin market based on its segments like applications, routes of administration, clinical trials, and major regions.
The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analyzing the market based on the SWOT and Porter’s Five Forces models.
Get a Free Sample Report with Table of Contents – https://www.expertmarketresearch.com/reports/immunoglobulin-market/requestsample
The key highlights of the report include:
Market Overview (2018-2028)
• Historical Market Size (2020): About USD 11.9 billion
• Forecast CAGR (2023-2028): 7.1%
Geographically, North America occupies a significant share of the global market for immunoglobulin. This can be associated with the flourishing healthcare sector in the region and advances in antibody therapies. The market further witnessed growth with the outbreak of COVID-19, which led to a massive increase in clinical trials of immunoglobulin across various phases of vaccine development, thereby contributing to the market growth.
Further, immunoglobulin finds its applications across various conditions, the market is being driven by the various clinical trials on the development of therapies for fighting such disorders. Moreover, improvements in the research and development sector for the creation of new products for the control of diseases are expected to drive market growth.
Industry Definition and Segmentation
An immunoglobulin refers to a protein biologically produced by plasma cells and other lymphocytes. Also known as an antibody, immunoglobulin is used by the immune system to detect and destroy disease-causing pathogens. Commercial immunoglobulin is a blood product obtained through the process of fractionation and purification for therapeutic and research applications.
The market, based on application, the market can be based into:
• Immunodeficiency Diseases
• Congenital AIDS
• Chronic Lymphocytic Leukaemia
• Myasthenia Gravis
• Multifocal Motor Neuropathy
• Kawasaki Disease
• Guillain-Barre Syndrome
On the basis of route of administration, the market division includes:
The market can be broadly categorised on the basis of clinical trials into:
The regional markets for immunoglobulin include:
• North America
• Asia Pacific
• Latin America
• Middle East and Africa
The growth in the global market for immunoglobulin is being driven by the increasing prevalence of immunodeficiency diseases and the emergence of enhanced purification techniques which offer a better yield of plasma. In addition to this, immunoglobulin finds various applications in the treatment of neurological disorders, thereby contributing to the growth of the global market.
Moreover, based on the route of administration, the intravenous segment holds a significant share in the market due to the easy availability of products and quick absorption rate of the intravenous method. Looking forward, the market is expected to be driven by rising investments in research and development (R&D) activities.
Key Market Players
The major players in the market are Biotest AG, Octapharma AG, Baxter International Inc., China Biologics Products Inc., and Grifols SA. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.
Company Name: Claight Corporation
Contact Person: Ana John, Business Consultant
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA